Arena Pharmaceuticals Inc...

NASDAQ: ARNA · Real-Time Price · USD
99.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Arena Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
54K
Cost of Revenue
n/a
Gross Profit
54K
Operating Income
-612.27M
Interest Income
1.43M
Pretax Income
-616.43M
Net Income
-620.59M
Selling & General & Admin
126.2M
Research & Development
419.51M
Other Expenses
8.64M
Operating Expenses
554.35M
Interest Expense
4.16M
Selling & Marketing Expenses
n/a
Cost & Expenses
554.35M
Income Tax Expense
4.16M
Shares Outstanding (Basic)
54.77M
Shares Outstanding (Diluted)
54.77M
EPS (Basic)
-11.33
EPS (Diluted)
-11.33
EBITDA
-608.4M
EBIT
-612.27M
Depreciation & Amortization
3.87M